{"id":"W4295828440","doi":"10.1016/j.annonc.2022.07.1492","title":"1360MO Quality of life and patient-relevant endpoints with darolutamide in the phase III ARASENS study","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"Cliniques Universitaires Saint-Luc; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Medical Research Council; Université Catholique de Louvain; Bayer HealthCare; University College London; Bayer","keywords":"Medicine; Docetaxel; Prostate cancer; Internal medicine; Cumulative incidence; Incidence (geometry); Rash; Androgen deprivation therapy; Adverse effect; Clinical endpoint; Cancer; Randomized controlled trial; Cohort","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001840046,0.0008137779,0.001510028,0.0001987292,0.0002207368,0.0006413308,0.0004087421,0.0005162344,0.002205079],"category_scores_gemma":[0.001035897,0.0001974328,0.00250261,0.0003223935,0.00036791,0.0004236244,0.0003725553,0.001865155,0.0003723146],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006047506,"about_ca_system_score_gemma":0.0009846251,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008177442,"about_ca_topic_score_gemma":0.002358255,"domain_scores_codex":[0.9992889,0.0004572922,0.00002743124,0.00005692385,0.00007498622,0.00009452075],"domain_scores_gemma":[0.999451,0.0001286977,0.0001670512,0.00005379219,0.00005063193,0.0001488093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8792433,0.007188784,0.02141997,0.0009490167,0.007713223,0.0001045133,0.00008660551,0.003407848,0.01004691,0.0004616668,0.003729727,0.06564841],"study_design_scores_gemma":[0.5215955,0.2607159,0.1868176,0.0002135588,0.008262549,0.0003316308,0.0001397242,0.004097897,0.005235011,0.001044812,0.01145928,0.00008643166],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907824,0.004181325,0.000280958,0.0003932762,0.0001031488,0.0003521112,0.001923819,0.00003624834,0.001946709],"genre_scores_gemma":[0.9923587,0.00180638,0.0006503576,0.0003827272,0.00009308141,0.0005379597,0.002356108,0.00001754648,0.001797025],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002205079,"threshold_uncertainty_score":0.009731174,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1307093785940786,"score_gpt":0.4640188743778277,"score_spread":0.333309495783749,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}